AnnouncementAugust 31, 2023
PHC Group Announces New Headquarters Office Location in Central Tokyo
PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) will move the headquarters functions of PHCHD and its wholly-owned subsidiary PHC Corporation to a new location in Tokyo: the Dai-ichi Life Hibiya First building near Hibiya Park. The relocation was approved at the 10th Annual General Meeting of Shareholders held on June 23, 2023, and is scheduled to be completed in April 2024.
PHCHD expects this move from its current location in Nishi-Shimbashi to drive operational efficiency, improve collaboration, and reduce expenses in headquarters. In addition to being more conveniently located near major train stations, the new space will allow the headquarters functions of PHCHD and PHC Corporation to be fully integrated on one floor and create an environment that better supports learning and talent development, advancing the Human Resources goals of PHCHD’s mid-term plan, or Value Creation Plan (FY22-FY25)*.
1. New headquarters address:
Dai-ichi Life Hibiya First Building, 15th Floor, Yurakucho 1-13-2, Chiyoda-ku, Tokyo
(Includes headquarters departments of PHCHD and PHC Corporation, currently based in Nishi-Shimbashi, Minato-ku, Tokyo)
2. Start of operations at new office: April 2024 (planned)
- 1 minute walk from Tokyo Metro and Toei Mita Line Hibiya Station
- 2 minute walk from JR Yurakucho Station
（*）Mid-term plan for FY22-FY25 announced by PHCHD:www.phchd.com/global/about/vcp
About PHC Holdings Corporation
PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries include PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia Holdings Ltd., Wemex Corporation, and LSI Medience Corporation. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, diagnostics and life sciences. The consolidated net sales in FY2022 were JPY 356.4 billion with global distribution of products and services in more than 125 countries and regions. PHC Group is a collective term referring to PHC Holdings Corporation and its subsidiaries.